APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Cheng-Kuei Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, No. 35, Xiao-Tong Road, Tainan 704, Taiwan. Hauptthemen laut MEDLINE: Cisplatin, DNA Repair, DNA Replication, DNA-(Apurinic or Apyrimidinic Site) Lyase. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chia-Yi Christian Hospital, Chi Mei Medical Center.
Abstract (Originalsprache)
Replication stress converts the stalled forks into reversed forks, which is an important protection mechanism to prevent fork degradation and collapse into poisonous DNA double-strand breaks (DSBs). Paradoxically, the mechanism also acts in cancer cells to contribute to chemoresistance against various DNA-damaging agents. PARP1 binds to and is activated by stalled forks to facilitate fork reversal. Aprataxin and polynucleotide kinase/phosphatase-like factor (APLF) binds to PARP1 through the poly(ADP-ribose) zinc finger (PBZ) domain and is known to be involved in non-homologous end joining (NHEJ). Here, we identify a novel function of APLF involved in interstrand DNA crosslink (ICL) repair and fork protection. We demonstrate that PARP1 activity facilitates the APLF recruitment to stalled forks, enabling the FANCD2 recruitment to stalled forks. The depletion of APLF sensitizes cells to cisplatin, impairs ICL repair, reduces the FANCD2 recruitment to stalled forks, and results in nascent DNA degradation by MRE11 nucleases. Additionally, cisplatin-resistant cancer cells show high levels of APLF and homologous recombination-related gene expression. The depletion of APLF sensitizes cells to cisplatin and results in fork instability. Our results reveal the novel function of APLF to facilitate ICL repair and fork protection, thereby contributing to cisplatin-resistant phenotypes of cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, No. 35, Xiao-Tong Road, Tainan 704, Taiwan.
- Department of Life Sciences, National Cheng Kung University, No. 1 University Road, Tainan City701, Taiwan.
- Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.
- Department of Public Health & Institute of Environmental and Occupational Health Sciences, College of Public Health, National Taiwan University, Taiwan.
- Department of Urology, An Nan Hospital, China Medical University, Tainan, Taiwan.
- Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.
ORCID-Profile: Hungjiun Liaw, Wen-Pin Su
Förderung
- National Science and Technology Council
- Chia-Yi Christian Hospital
- Chi Mei Medical Center
- Ann-Nan hospital
- National Cheng Kung University
- Core Facility of Taiwan Mouse Clinic and Animal Consortium
- National Cheng Kung University Hospital
Zitieren
APA
Wu, C. K., Shiu, J. L., Wu, C. L., Hung, C. F., Ho, Y. C., Chen, Y. T., Tung, S. Y., Yeh, C. F., Shen, C. H., Liaw, H., & Su, W. P. (2024). APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae211
Vancouver
Wu CK, Shiu JL, Wu CL, Hung CF, Ho YC, Chen YT, et al. APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae211
BibTeX
@article{Wu2024,
author = {Wu, Cheng-Kuei and Shiu, Jia-Lin and Wu, Chao-Liang and Hung, Chi-Feng and Ho, Yen-Chih and Chen, Yen-Tzu and Tung, Sheng-Yung and Yeh, Cheng-Fa and Shen, Che-Hung and Liaw, Hungjiun and Su, Wen-Pin},
title = {APLF facilitates interstrand DNA crosslink repair and replication fork protection to confer cisplatin resistance},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae211}
}
EUVIMED